Low back pain is the leading cause of disability worldwide and is strongly associated with degeneration of the intervertebral disc (IVD). During degeneration the nucleus pulposus (NP) in the core of the IVD, is affected by altered matrix synthesis, increased degradation, and cell loss. Strategies combining regenerative cell sources with injectable biomaterials could provide a therapeutic approach to treating IVD-degeneration related back pain. The juvenile cells of the NP, known as notochordal cells (NC), could provide both anabolic and anti-catabolic responses for disc regeneration. However, their behaviour within biomaterial delivery systems has not been investigated. Here, porcine NCs were incorporated into three injectable hydrogels: Albugel (an albumin/hyaluronan hydrogel), NPgel (a L-pNIPAM-co-DMAc hydrogel) and NPgel with decellularized NC-matrix powder (dNCM). The NCs and biomaterial constructs were cultured for up to 4 weeks under 5 % oxygen (n = 3 biological repeats). The ability of biomaterials to maintain NC viability, phenotype and extracellular matrix synthesis and deposition was investigated through histological, immunohistochemical and glycosaminoglycans analysis. NCs survived in all three biomaterials after 4 weeks, whilst phenotype and cell clustering were maintained to a greater extent in NPgel and Albugel. Thus, these biomaterials could facilitate maintenance of the NC phenotype, support matrix deposition and be a basis for future IVD regeneration strategies.